Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study

MLA

Eleonora Dal Grande, et al. “Gout Prevalence and Predictors of Urate-Lowering Therapy Use: Results from a Population-Based Study.” Arthritis Research & Therapy, vol. 20, no. 1, July 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13075-018-1633-9.

APA

Eleonora Dal Grande, Huai Leng Pisaniello, Greg R. Sharplin, Marie Longo, David Alejandro González-Chica, Christopher Hill, Samuel L Whittle, Susan C. Lester, Tiffany K. Gill, & Nigel Stocks. (2018). Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study. Arthritis Research & Therapy, 20(1), 1–10. https://doi.org/10.1186/s13075-018-1633-9

Chicago

Eleonora Dal Grande, Huai Leng Pisaniello, Greg R. Sharplin, Marie Longo, David Alejandro González-Chica, Christopher Hill, Samuel L Whittle, Susan C. Lester, Tiffany K. Gill, and Nigel Stocks. 2018. “Gout Prevalence and Predictors of Urate-Lowering Therapy Use: Results from a Population-Based Study.” Arthritis Research & Therapy 20 (1): 1–10. doi:10.1186/s13075-018-1633-9.